Val­ne­va tops up loan by $100M; Ipsen gets a vouch­er

Val­ne­va is ex­tend­ing an ex­ist­ing loan by an ad­di­tion­al $100 mil­lion in an­tic­i­pa­tion of com­mer­cial­iz­ing its chikun­gun­ya vac­cine if ap­proved lat­er this year and for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER